🇺🇸 FDA
Patent

US 9809569

Process for producing heterocyclic compound

granted A61PA61P3/10A61P43/00

Quick answer

US patent 9809569 (Process for producing heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61P, A61P3/10, A61P43/00